ConductScience.org, home

Paper23716995

Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes.

Lv WS and 9 others. World J Gastroenterol, 2013. Cited by 73 papers, by iCite.

Cite this record

ConductScience Library. Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes. Papers, record 23716995. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23716995

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes.
PubMed
Journal
World J Gastroenterol
PubMed
Year
2013
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
73
iCite
Relative citation ratio, by iCite
2.67
iCite
Revised in PubMed
2026-01-28
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lv WSWen-Shan
2Sun RXRui-Xia
3Gao YYYan-Yan
4Wen JPJun-Ping
5Pan RFRong-Fang
6Li LLi
7Wang JJing
8Xian YXYu-Xin
9Cao CXCai-Xia
10Zheng MMing

Source PubMed

Download CSV of authors

Topics24

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Diabetes Mellitus, Type 2Major topic
Diabetic AngiopathiesMajor topic
Fatty LiverMajor topic
MicrocirculationMajor topic
Aged
Chi-Square Distribution
China
Cross-Sectional Studies
Diabetic Nephropathies
Diabetic Retinopathy
Dyslipidemias
Female
Humans
Hypertension
Logistic Models
Male
Middle Aged
Non-alcoholic Fatty Liver Disease
Obesity
Odds Ratio
Predictive Value of Tests
Prevalence
Risk Factors
Ultrasonography

Source PubMed

Download CSV of topics

References31

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114762783Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma.Gastroenterology2004https://conductscience.org/library/papers/14762783PubMed
221478462Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study.Diabetes Care2011https://conductscience.org/library/papers/21478462PubMed
319038040Enhanced serum concentrations of transforming growth factor-beta1 in simple fatty liver: is it really benign?J Transl Med2008https://conductscience.org/library/papers/19038040PubMed
419051703Clinicopathological profile of hepatic involvement in type-2 diabetes mellitus and its significance.J Assoc Physicians India2008https://conductscience.org/library/papers/19051703PubMed
520818974Risk factors for microvascular complications of diabetes among South Indian subjects with type 2 diabetes--the Chennai Urban Rural Epidemiology Study (CURES) Eye Study-5.Diabetes Technol Ther2010https://conductscience.org/library/papers/20818974PubMed
620335585Prevalence of diabetes among men and women in China.N Engl J Med2010https://conductscience.org/library/papers/20335585PubMed
719414942Concomitant macro and microvascular complications in diabetic nephropathy.Saudi J Kidney Dis Transpl2009https://conductscience.org/library/papers/19414942PubMed
820664019Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes.Diabetes Care2010https://conductscience.org/library/papers/20664019PubMed
917729403Pathogenesis and management issues for non-alcoholic fatty liver disease.World J Gastroenterol2007https://conductscience.org/library/papers/17729403PubMed
1021184785Diabetes is a progression factor for hepatic fibrosis in a high fat fed mouse obesity model of non-alcoholic steatohepatitis.J Hepatol2011https://conductscience.org/library/papers/21184785PubMed
1116374859Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice.Hepatology2006https://conductscience.org/library/papers/16374859PubMed
1216447287Nonalcoholic fatty liver disease: from steatosis to cirrhosis.Hepatology2006https://conductscience.org/library/papers/16447287PubMed
1319262374Nonalcoholic fatty liver disease in type 2 diabetes mellitus.Curr Opin Endocrinol Diabetes Obes2009https://conductscience.org/library/papers/19262374PubMed
1417941863Diabetic neuropathy is closely associated with arterial stiffening and thickness in Type 2 diabetes.Diabet Med2007https://conductscience.org/library/papers/17941863PubMed
1518001543[Study on prevalence and risk factors of fatty liver of patients with type 2 diabetes].Zhonghua Yi Xue Za Zhi2007https://conductscience.org/library/papers/18001543PubMed
1616953843Incretin mimetics as a novel therapeutic option for hepatic steatosis.Liver Int2006https://conductscience.org/library/papers/16953843PubMed
1719501581Hepatic insulin resistance, metabolic syndrome and cardiovascular disease.Clin Biochem2009https://conductscience.org/library/papers/19501581PubMed
1815727689[Epidemiological survey of prevalence of fatty liver and its risk factors in a general adult population of Shanghai].Zhonghua Gan Zang Bing Za Zhi2005https://conductscience.org/library/papers/15727689PubMed
1917547834NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes.Curr Diab Rep2007https://conductscience.org/library/papers/17547834PubMed
2017295757Non-alcoholic fatty liver disease: further expression of the metabolic syndrome.J Gastroenterol Hepatol2007https://conductscience.org/library/papers/17295757PubMed

See all 31 referencesDownload CSV of references

Cited by45

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 73 citations.

PMIDTitleJournalYearIn PapersSource
41441969Risk of Microvascular and Macrovascular Complications in Patients with Type 2 Diabetes and Metabolic Dysfunction-Associated Steatohepatitis: A Retrospective Cohort Study.Diabetes Ther2026https://conductscience.org/library/papers/41441969PubMed
40894805Atherogenic Combined Index is Independently Associated with MASLD in Type 2 Diabetes: A Cross-Sectional Study.Diabetes Metab Syndr Obes2025https://conductscience.org/library/papers/40894805PubMed
39859020Retinopathy in Metabolic Dysfunction-Associated Steatotic Liver Disease.Medicina (Kaunas)2024https://conductscience.org/library/papers/39859020PubMed
39757660Exploring the Prevalence and Coexistence of Metabolic Dysfunction-associated Steatotic Liver Disease in Type 2 Diabetes Mellitus Patients Using Ultrasound: A Cross-sectional StudyCurr Med Imaging2025https://conductscience.org/library/papers/39757660PubMed
38899241Nonalcoholic Fatty Liver Disease in Shift Workers and Its Effect on Peripheral Nerve Conduction: A Cross-Sectional Study.Cureus2024https://conductscience.org/library/papers/38899241PubMed
38232082Causal associations between liver enzymes and diabetic microvascular complications: A univariable and multivariable Mendelian randomization.PLoS One2024https://conductscience.org/library/papers/38232082PubMed
38125279A decreased level of high-density lipoprotein is a possible risk factor for type 2 diabetes mellitus: A review.Health Sci Rep2023https://conductscience.org/library/papers/38125279PubMed
37828942
Metabolic characteristics of non-obese and obese metabolic dysfunction-associated fatty liver disease in type 2 diabetes mellitus and its association with diabetic peripheral neuropathy and diabetic retinopathy.
Front Med (Lausanne)2023https://conductscience.org/library/papers/37828942PubMed
37511760Retinal Vascular Lesions in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.J Pers Med2023https://conductscience.org/library/papers/37511760PubMed
37342261Non-alcoholic fatty liver disease and incidence of microvascular complications of diabetes in patients with type 2 diabetes: a prospective cohort study.Front Endocrinol (Lausanne)2023https://conductscience.org/library/papers/37342261PubMed
37002268Association between nonalcoholic fatty liver disease and peripheral neuropathy in US population, a cross-sectional study.Sci Rep2023https://conductscience.org/library/papers/37002268PubMed
36938188Relationship Between Vitamin D Deficiency and Non-alcoholic Fatty Liver Disease: A Cross-Sectional Study From a Tertiary Care Center in Northern India.Cureus2023https://conductscience.org/library/papers/36938188PubMed
36909318Aspartate aminotransferase/alanine aminotransferase ratio was associated with type 2 diabetic peripheral neuropathy in a Chinese population: A cross-sectional study.Front Endocrinol (Lausanne)2023https://conductscience.org/library/papers/36909318PubMed
36744164Influence of non-alcoholic fatty liver disease on non-variceal upper gastrointestinal bleeding: A nationwide analysis.World J Hepatol2023https://conductscience.org/library/papers/36744164PubMed
36526962Elevated fasting glucose level increases the risk of fatty liver disease: a 10-year study of 31,154 individuals.BMC Gastroenterol2022https://conductscience.org/library/papers/36526962PubMed
36458094The presence of diabetic retinopathy closely associated with the progression of non-alcoholic fatty liver disease: A meta-analysis of observational studies.Front Mol Biosci2022https://conductscience.org/library/papers/36458094PubMed
36387855Integrated analysis of potential gene crosstalk between non-alcoholic fatty liver disease and diabetic nephropathy.Front Endocrinol (Lausanne)2022https://conductscience.org/library/papers/36387855PubMed
35978658Prevalence of nonalcoholic fatty liver disease and its association with age in patients with type 2 diabetes mellitus.World J Hepatol2022https://conductscience.org/library/papers/35978658PubMed
35885657Simultaneously Screening for Liver Steatosis and Fibrosis in Romanian Type 2 Diabetes Mellitus Patients Using Vibration-Controlled Transient Elastography with Controlled Attenuation Parameter.Diagnostics (Basel)2022https://conductscience.org/library/papers/35885657PubMed
35268466The Coexistence of Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus.J Clin Med2022https://conductscience.org/library/papers/35268466PubMed

See all 45 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
GGT12678PubTator's text mininghttps://conductscience.org/library/genes/2678NCBI Gene
GPT2875PubTator's text mininghttps://conductscience.org/library/genes/2875NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23716995

GET https://conductscience.org/api/papers/v1/23716995/references?page=2